Hollsteen
← Astera Labs

Research and development

Flow – sum over the period · $M

QuartersFiscal years

$MResearch and development · Q1 2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q2 2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q3 2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q4 2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q1 2017: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q2 2017: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q3 2017: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q4 2017: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q1 2018: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q2 2018: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q3 2018: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q4 2018: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q1 2019: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q2 2019: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q3 2019: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q4 2019: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q1 2020: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q2 2020: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q3 2020: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q4 2020: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q1 2021: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q2 2021: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q3 2021: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q4 2021: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q1 2022: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q2 2022: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q3 2022: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q4 2022: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q1 2023: $15.0M · 10-Q 0001736297-24-000006 filed May 8, 2024Research and development · Q2 2023: $18.0M · 10-Q 0001736297-24-000018 filed Aug 7, 2024Research and development · Q3 2023: $21.0M · 10-Q 0001736297-24-000043 filed Nov 5, 2024Research and development · Q4 2023: $20.0M · derived · 10-K 0001736297-25-000003 filed Feb 14, 2025Research and development · Q1 2024: $54.0M · 10-Q 0001736297-24-000006 filed May 8, 2024Research and development · Q2 2024: $40.0M · 10-Q 0001736297-24-000018 filed Aug 7, 2024Research and development · Q3 2024: $51.0M · 10-Q 0001736297-24-000043 filed Nov 5, 2024Research and development · Q4 2024: $57.0M · derived · 10-K 0001736297-26-000010 filed Feb 20, 2026Research and development · Q1 2025: $65.0M · 10-Q 0001736297-25-000031 filed May 7, 2025Research and development · Q2 2025: $67.0M · 10-Q 0001736297-25-000098 filed Aug 6, 2025Research and development · Q3 2025: $79.0M · 10-Q 0001736297-25-000147 filed Nov 5, 2025Research and development · Q4 2025: $94.0M · derived · 10-K 0001736297-26-000010 filed Feb 20, 2026Research and development · Q1 2026: $126M · 10-Q 0001736297-26-000020 filed May 6, 2026Research and development · Q2 2026: $136M · 10-Q 0001736297-26-000035 filed Aug 5, 2026missing66.7135.915.3Q1 2016Q2 2026Q2 2025
$MResearch and development · Q3 2024: $51.0M · 10-Q 0001736297-24-000043 filed Nov 5, 2024Research and development · Q4 2024: $57.0M · derived · 10-K 0001736297-26-000010 filed Feb 20, 2026Research and development · Q1 2025: $65.0M · 10-Q 0001736297-25-000031 filed May 7, 2025Research and development · Q2 2025: $67.0M · 10-Q 0001736297-25-000098 filed Aug 6, 2025Research and development · Q3 2025: $79.0M · 10-Q 0001736297-25-000147 filed Nov 5, 2025Research and development · Q4 2025: $94.0M · derived · 10-K 0001736297-26-000010 filed Feb 20, 2026Research and development · Q1 2026: $126M · 10-Q 0001736297-26-000020 filed May 6, 2026Research and development · Q2 2026: $136M · 10-Q 0001736297-26-000035 filed Aug 5, 202666.7135.950.7Q3 2024Q2 2026Q2 2025
Q2 2025
66.7$M
All values (14)
PeriodValue ($M)Status
Q2 2026135.9reported
Q1 2026125.6reported
Q4 202593.8derived
Q3 202578.9reported
Q2 202566.7reported
Q1 202564.6reported
Q4 202456.5derived
Q3 202450.7reported
Q2 202440.1reported
Q1 202453.6reported
Q4 202319.7derived
Q3 202320.6reported
Q2 202317.9reported
Q1 202315.3reported

28 periods without value hidden · Show gaps with reason · CSV with all sources · Technical ID: rnd

More metrics for Astera Labs

Income statement

Per share

Balance sheet

Cash flow

Revenue by segment/product/region

Sources & calculation
Value
$67.0M
Period
Q2 2025, ended Jun 30, 2025 · quarterly value (3 months, not cumulative)
Source
10-Q, filed Aug 6, 2025 · 0001736297-25-000098
Location
us-gaap:ResearchAndDevelopmentExpense
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$67.0MAug 6, 202510-Q 0001736297-25-000098reported · confidence 1. · current